| Host Immune Factor (HIF) Regulating This MIC |
| Adrenomedullin |
| HIF ID |
HIFM0003 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Ultrastructural analyses have shown that treatment with Adrenomedullin(AM) causes a cell-wall disruption in Escherichia coli. |
[1] |
| Cathelicidin antimicrobial peptide |
| HIF ID |
HIFM0014 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
LL-37 showed the high antimicrobial activity against Escherichia coli, and its minimal inhibition concentration (MIC) determined for Escherichia coli was 1.65 uM. The LL-37 could permeabilize cell membranes of Escherichia coli by increasing the beta-galactosidase activity. |
[2] |
| Melanocyte-stimulating hormone alpha |
| HIF ID |
HIFM0064 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The ability of the Escherichia coli ClpB protein to stimulate production of Alpha-MSH crossreactive auto-Abs was validated. |
[3] |
| C-X-C motif chemokine 14 |
| HIF ID |
HIFM0077 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The recombinant CXCL14 demonstrates antimicrobial effects against Escherichia coli at 10g/ml. |
[4] |
| Human beta defensin 3 |
| HIF ID |
HIFM0079 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The expression of HBD3 increases the cellular uptake of Escherichia coli and self-DNA into mouse Flt-3 induced dendritic cells (FLDCs) (p-value<0.01). |
[5] |
| Defensin beta 120 |
| HIF ID |
HIFM0084 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The DEFB120 peptide possessed potent killing with LD90 of 60g/ml against Escherichia coli and Candida albicans. |
[6] |
| Human beta-defensin 10 |
| HIF ID |
HIFM0091 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The hBD10 inhibited the growth of Escherichia coli at the concentration of 25M for 6 hours. |
[7] |
| Human beta defensin 2 |
| HIF ID |
HIFM0092 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Escherichia coli strains are able to induce secretion of hBD-2 from enterocytes. |
[8] |
| Eosinophil cationic protein |
| HIF ID |
HIFM0094 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The RNase 3 showed bactericidal activity against Escherichia coli when the hemolytic activity of 11.2M. |
[9] |
| Isoform 2 |
| HIF ID |
HIFM0106 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Membrane blebbing was observed on Escherichia coli incubated with alarin at 20M. |
[10] |
| Liver-expressed antimicrobial peptide 1 |
| HIF ID |
HIFM0111 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The IC50 value of Hepcidin for Escherichia coli is 18.66M. |
[11] |
| Interleukin 26 |
| HIF ID |
HIFM0146 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The recombinant human IL-26 inhibited the growth of gram-negative bacteria (such as Escherichia coli) by direct bactericidal action and the median minimum inhibitory concentration values were in the range of 8.6 to 18.6 M. |
[12] |
| Regenerating islet-derived protein 3-beta |
| HIF ID |
HIFM0197 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The recombinant purified RegIII had bactericidal activity against Escherichia coli and the effective doses for bactericidal activity were below 2.5 M. |
[13] |
| Ribonuclease 7 |
| HIF ID |
HIFM0201 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
RNase 7 showed potent antimicrobial activity against uropathogenic Escherichia coli. |
[14] |
| Human calcitermin |
| HIF ID |
HIFM0206 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Calcitermin of 50ug/ml had inhibitory activity against Escherichia coli. |
[15] |
| Secretory leukocyte protease inhibitor |
| HIF ID |
HIFM0208 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Secretory leukocyte protease inhibitoris (SLPI) has antiprotease activity and is detrimental to Escherichia coli. |
[16] |
| Human alpha-synuclein |
| HIF ID |
HIFM0209 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Colonization with curli-producing Escherichia coli can promote alpha-Syn pathology in the gut and the brain. |
[17] |
| Human lactoferricin |
| HIF ID |
HIFM0237 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Lactoferricin has shown antibacterial activity against enterotoxigenic Escherichia coli. |
[18] |
| HD-5(1-13) |
| HIF ID |
HIFM0288 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Additional big HD-5113 treatment led to bigger aggradation inside the bacteria Escherichia coli MC1000. |
[19] |
| hGAPDH(2-32) |
| HIF ID |
HIFM0293 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The antifungal activities hGAPDH(2-32) with 10 g/ml is less active against Escherichia coli. |
[20] |
| Human neutrophil peptide-1 |
| HIF ID |
HIFM0305 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The lethal concentrations of HNP-1 for killing Escherichia coli is 1.0M. |
[21] |
| Human neutrophil peptide-4 |
| HIF ID |
HIFM0308 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Human neutrophil defensin 4 (HNP4) displays more than 100-fold higher activity against Escherichia coli compared with other defensins. |
[22] |
| Human Salvic peptide |
| HIF ID |
HIFM0310 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Salvic expresses 46 amino acids peptide (pI=9.45) possessing an antimicrobial activity on Escherichia coli. |
[23] |
| Koebnerisin |
| HIF ID |
HIFM0325 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Escherichia coli could significantly induce human S100A15 transcript abundance. |
[24] |
| Semenogelin I-derived AMP 29-residues, human |
| HIF ID |
HIFM0326 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
SgI-29 has a defense against Escherichia coli. |
[10] |
| SPINK9-v1 |
| HIF ID |
HIFM0328 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
In the presence of 1% of tryptic soy broth (TSB), rSPINK9-v1 showed high killing activity against Escherichia coli; in contrast, without the presence of TSB, rSPINK9-v1 showed no killing activity. |
[25] |
| Ubiquicidin |
| HIF ID |
HIFM0333 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The abundance of Escherichia coli is associated with Ubiquicidin. |
[26] |
| Ubiquitin |
| HIF ID |
HIFM0334 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Escherichia coli bacteria could modulate ubiquitin proteasome system (UPS) turnover. |
[27] |
| Human beta-defensin-28 |
| HIF ID |
HIFM0338 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Human HBD-28 variant has inhibitory effect against pathogenic bacteria Escherichia coli. |
[28] |
| Human drosomycin-like defensin |
| HIF ID |
HIFM0298 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Neither Human drosomycin-like defensin nor drosomycin was active against the bacteria Escherichia coli. |
[29] |
| B cells |
| HIF ID |
HIFC0001 |
HIF Info
|
Class |
B cells (BCs) |
| Description |
Escherichia coli induced B cells to generate CNS-reactive autoantibodies. |
[30] |
| IgG plasma B cell |
| HIF ID |
HIFC0219 |
HIF Info
|
Class |
B cells (BCs) |
| Description |
Enterotoxigenic Escherichia coli (ETEC) vaccine exhibited positive IgG plasma cell responses. |
[31] |
| IgA plasma B cell |
| HIF ID |
HIFC0221 |
HIF Info
|
Class |
B cells (BCs) |
| Description |
The expression of Enterotoxigenic Escherichia coli (ETEC) vaccine exhibited positive IgA plasma cell responses. |
[31] |
| T-cell surface glycoprotein CD1b |
| HIF ID |
HIFM0039 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
CD1b dextramers loaded with natural PG from Escherichia coli. |
[32] |
| DNAX accessory molecule-1 |
| HIF ID |
HIFM0042 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The ectodomain of human CD226 (hCD226-ecto) was expressed in Escherichia coli cells as inclusion bodies. |
[33] |
| Natural killer cell receptor 2B4 |
| HIF ID |
HIFM0043 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
A single-chain Fv construct of the 2B4 T-cell receptor has been made and expressed in Escherichia coli as bacterial inclusion bodies. |
[34] |
| Tumor necrosis factor receptor superfamily member 7 |
| HIF ID |
HIFM0044 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The abundance of Escherichia coli was associated with higher numbers of CD20(+) B cells that expressed the memory marker CD27 at 4 and 18 month of age. |
[35] |
| B7 homolog 3 |
| HIF ID |
HIFM0045 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
B7-H3 based on its emerging potential as a therapeutic target displayed high expression levels in Escherichia coli. |
[36] |
| CD40 ligand |
| HIF ID |
HIFM0051 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
T helper cells up-regulates CD40L (CD154) when stimulated with antigens from Escherichia coli. |
[37] |
| CEA cell adhesion molecule 1 |
| HIF ID |
HIFM0057 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
CEACAM1 serves as a receptor for Escherichia coli pathogens in humans. |
[38] |
| Cytotoxic T-lymphocyte-associated protein 4 |
| HIF ID |
HIFM0068 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
Changes in CTLA-4 activity regulate the abundance of Escherichia coli. |
[39] |
| T cell immunoglobulin 3 |
| HIF ID |
HIFM0110 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
TIM-3 expressed in neutrophils is directly involved in reducing the abundance of Escherichia coli. |
[40] |
| Indoleamine 2,3-dioxygenase 1 |
| HIF ID |
HIFM0120 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
Indoleamine 2,3-dioxygenase (IDO) promotes uropathogenic Escherichia coli (UPEC) colonization of bladder in murine cystitis and survival of extracellular bacteria. |
[41] |
| ICOS ligand |
| HIF ID |
HIFM0125 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
Escherichia coli stimulation resulted in an increased percentage of CD11c-positive cells expressing B7RP-1 (ICOSLG). |
[42] |
| Lymphocyte function-associated antigen 3 |
| HIF ID |
HIFM0164 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The abundance of Escherichia coli is associated with CD58 activation. |
[43] |
| Tumor necrosis factor ligand superfamily member 15 |
| HIF ID |
HIFM0224 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The p38 MAPK inhibitors significantly reduced Escherichia coli induced TL1A mRNA in both monocytes (p-value<0.001). |
[44] |
| Tumor necrosis factor ligand superfamily member 18 |
| HIF ID |
HIFM0225 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The extracellular domain of human GITR ligand has been expressed and purified in Escherichia coli. |
[45] |
| Tumor necrosis factor ligand superfamily member 9 |
| HIF ID |
HIFM0228 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
The extracellular domain of the 4-1BBL ligand fused with glutathione-S-transferase is expressed in Escherichia coli. |
[46] |
| Tumor necrosis factor receptor superfamily member 18 |
| HIF ID |
HIFM0230 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
GITR contributes to the systemic adjuvanticity of the Escherichia coli heat-labile enterotoxin. |
[47] |
| T-cell surface glycoprotein CD1c |
| HIF ID |
HIFM0040 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
CD1c protein changed the abundance of Escherichia coli. |
[48] |
| C-C motif chemokine 20 |
| HIF ID |
HIFM0023 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
CCL20 has a property conferring a direct antimicrobial enzymatic activity against Escherichia coli. |
[49] |
| C-X-C motif chemokine 2 |
| HIF ID |
HIFM0069 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
The expression of CXCL2 was found to positively correlate with the pro-inflammatory bacterium Escherichia coli. |
[50] |
| C-X-C motif chemokine 1 |
| HIF ID |
HIFM0109 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
Basolateral Escherichia coli infection induced about 60-fold increase in CXCL1 transcription. |
[51] |
| Interferon-13 |
| HIF ID |
HIFM0132 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
Escherichia coli increased the IL-13 expression. |
[52] |
| Interferon-4 |
| HIF ID |
HIFM0149 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
Splenic TFF2 in attenuating SR-induced reduced protective ability against Escherichia coli (E. coli) pneumonia and increased expression of IL-4. |
[52] |
| Interferon-5 |
| HIF ID |
HIFM0150 |
HIF Info
|
Class |
Cytokine (Cyt) |
| Description |
Escherichia coli increased significantly the mRNA expression (p-value<0.01) of thehe pro-Th2 cytokine IL-5 (2.56 fold change) in IPEC-1 cells. |
[53] |
| Skin conventional dendritic cells |
| HIF ID |
HIFC0161 |
HIF Info
|
Class |
Dendritic cells (DCs) |
| Description |
Neutrophil recruitment by dermal skin conventional dendritic cells (cDC1s) was also observed during Escherichia coli. |
[54] |
| Conventional dendritic cells |
| HIF ID |
HIFC0164 |
HIF Info
|
Class |
Dendritic cells (DCs) |
| Description |
Escherichia coli infection led to a reproducible increase in TNF production by conventional dendritic cells in response to poly or lipopolysaccharide. |
[55] |
| Immunoglobulin alpha Fc receptor |
| HIF ID |
HIFM0097 |
HIF Info
|
Class |
Fc Receptor (FCR) |
| Description |
After targeting FcRI (CD89), neutrophils enhanced the effect of reducing Escherichia coli abundance. |
[56] |
| Neutrophils |
| HIF ID |
HIFC0029 |
HIF Info
|
Class |
Granulocytes (Gra) |
| Description |
The bacterium Escherichia coli could cross-react with melanocyte-stimulating hormone (alpha-MSH). |
[30] |
| Immunoglobulin M |
| HIF ID |
HIFM0266 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
IgM leads to protection against bacterial infection of Escherichia coli. |
[57] |
| Immunoglobulin G1 |
| HIF ID |
HIFM0269 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
Immunoglobulin G1 decreases the abundance of Escherichia coli. |
[58] |
| Immunoglobulin G |
| HIF ID |
HIFM0270 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
The 50-g dose of double mutant heat-labile enterotoxin (dmLT) of Enterotoxigenic Escherichia coli recipients trended toward stronger responses than the 100-g dose recipients by serum IgG (67% versus 33%, p-value= 0.22). |
[31] |
| Immunoglobulin E |
| HIF ID |
HIFM0271 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
Low Escherichia coli is positively associated with IgE immune responses. |
[59] |
| Immunoglobulin A |
| HIF ID |
HIFM0272 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
The monoclonal IgA antibodies W27 with potent relative binding ability against Escherichia coli (an optical density of about 4 at an antibody concentration of 50 ug/ml) could inhibit the enzymatic activity of the serine hydroxymethyltransferase, which resulted in growth suppression of Escherichia coli. When the concentrations of IgA W27 were 23 ug/ml, 70 ug/ml and 210 ug/ml, the cell growth of Escherichia coli was inhibited significantly in a dose-dependent manner (~108 cells, ~106 cells, ~103 cells, respectively) (p-value<0.05). |
[60] |
| Immunoglobulin D |
| HIF ID |
HIFM0277 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
IgD levels in uncinate tissue were significantly higher in patients who possessed pathogenic Escherichia coli bacterial growth compared with those without bacterial growth (p-value<0.05). |
[61] |
| Immunoglobulin G3 |
| HIF ID |
HIFM0267 |
HIF Info
|
Class |
Immunoglobulin (Ig) |
| Description |
Escherichia coli was associated with IgG3 response. |
[62] |
| Type 3 Innate Lymphoid Cells |
| HIF ID |
HIFC0009 |
HIF Info
|
Class |
Innate lymphoid cells (ILCs) |
| Description |
Innate lymphoid cell type 3Cderived interleukin-22 boosts the expression and production of lipocalin-2 (LCN-2) in intestinal epithelial cells (IECs) and resulting inhibiting growth of Escherichia coli. |
[63] |
| Macrophages |
| HIF ID |
HIFC0020 |
HIF Info
|
Class |
Macrophages (Mac) |
| Description |
Macrophages from adult colon excelled at taking up fluorescently labeled Escherichia coli into acidified vesicles. |
[64] |
| Killer-cell immunoglobulin-like receptor |
| HIF ID |
HIFM0250 |
HIF Info
|
Class |
MHC-I receptor (MHCIR) |
| Description |
Expression in Escherichia coli has been achieved by replacing three fourths of the transmembrane pore with the pore of a prokaryotic Kir channel. |
[65] |
| CD16 + monocytes |
| HIF ID |
HIFC0118 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
CD16+ monocytes expressed IL-6 in response to stimulation with LPS from Escherichia coli, and more than 80% of CD16+ monocytes expressed cytoplasmic IL-6. |
[66] |
| CD16- monocytes |
| HIF ID |
HIFC0119 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
CD16- monocytes expressed IL-6 in response to stimulation with LPS from Escherichia coli, although only about 60% of CD16- monocytes expressed IL-6. |
[66] |
| CD14+ monocytes |
| HIF ID |
HIFC0205 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
CD14+ monocytes have higher phagocytic activity than CD14- monocytes for Echerichia coli. |
[67] |
| CD14+ CD16+ monocytes |
| HIF ID |
HIFC0209 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
CD14+CD16+ monocytes increased in children with hemolytic uremic syndrome caused by infection with Shiga toxin-producing Escherichia coli bacteria. |
[68] |
| CD14- monocytes |
| HIF ID |
HIFC0213 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
Experiments performed with Echerichia coli showed that CD14- monocytes have lower phagocytic activity than CD14+ monocytes. |
[67] |
| TNF+ monocytes |
| HIF ID |
HIFC0215 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
The percentage of TNF-alpha producing monocytes increased after Escherichia coli infection from 11.5 % to 47.2% 4 hours post infectionem. |
[69] |
| GFP- monocytes |
| HIF ID |
HIFC0216 |
HIF Info
|
Class |
Monocytes (Mono) |
| Description |
Escherichia coli infection induced by stander-apoptosis of GFP- monocytes. |
[69] |
| Peripheral blood natural killer cells |
| HIF ID |
HIFC0181 |
HIF Info
|
Class |
Natural killer cells (NKCs) |
| Description |
Peripheral blood NK cells conferred protection against intestinal epithelial barrier damage induced by enterotoxigenic Escherichia coli in NCM460 cells in vitro. |
[70] |
| Nuclear receptor ROR-gamma |
| HIF ID |
HIFM0205 |
HIF Info
|
Class |
Retinoic acid receptor (RAR) |
| Description |
RORC expression was associated with Escherichia coli. |
[71] |
| CD3+ T cells |
| HIF ID |
HIFC0064 |
HIF Info
|
Class |
T cells (TCs) |
| Description |
Escherichia coli-induced TNF-like ligand 1A drived intestinal CD3+ T cells activation during colitis. |
[72] |
| T-cell surface glycoprotein CD4 |
| HIF ID |
HIFM0050 |
HIF Info
|
Class |
T-cell receptor (TCR) |
| Description |
Escherichia coli and B animalis reactive CD4+ T-cell lines were strongly restimulated when cultured with autologous monocytes loaded with Escherichia coli or B animalis lysates. |
[73] |
|
|
|
|
|
|